Dr. Reddy’s to Acquire Wockhardt’s Select Business Divisions for ~$259M in India

 Dr. Reddy’s to Acquire Wockhardt’s Select Business Divisions for ~$259M in India

Dr. Reddy’s to Acquire Wockhardt’s Select Business Divisions for ~$258M in India

Shots:

  • Dr. Reddy’s acquires Wockhardt’s select divisions of its branded generics business in India and other international territories of Nepal, Sri Lanka, Bhutan and Maldives for ~$259M (Rs.1850 crores)
  • The focus of the acquisition is to boost Dr. Reddy’s presence in the high growth therapy areas with the addition of Wockhardt’s Practin, Zedex, Bro-zedex, Tryptomer and Biovac to its portfolio
  • Dr. Reddy’s acquires Wockhardt’s select business divisions which include 62 brands in multiple therapy areas respiratory, neurology, VMS, dermatology, gastroenterology, pain and vaccines along with sales and marketing teams; and the manufacturing plant located in Baddi, Himachal Pradesh with all its employees

Click here to­ read full press release/ article | Ref: Business wire | Image: Livemint

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post